Human pegivirus viremia in HCV/HIV co-infected patients: Direct acting antivirals exert anti-pegivirus effects.

Hlavay, B A; Zhuo, R; Ogando, N; Charlton, C; Stapleton, J T; Klein, M B; Power, C

Hlavay, B A; Zhuo, R; Ogando, N; Charlton, C; Stapleton, J T; Klein, M B; Power, C.

Affiliation

Hlavay BA; Department of Medicine, University of Alberta, Edmonton, AB, Canada.
Zhuo R; Public Health Laboratory, Alberta Precision Laboratories, Edmonton, AB, Canada.
Ogando N; Department of Medicine, University of Alberta, Edmonton, AB, Canada.
Charlton C; Laboratory Medicine & Pathology, University of Alberta, Edmonton, AB, Canada; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, AB, Canada; Public Health Laboratory, Alberta Precision Laboratories, Edmonton, AB, Canada.
Stapleton JT; Departments of Internal Medicine and Microbiology, University of Iowa, Iowa City, Iowa, USA.
Klein MB; Department of Medicine, McGill University Health Centre, Montreal, QC, Canada.
Power C; Department of Medicine, University of Alberta, Edmonton, AB, Canada. Electronic address: chris.power@ualberta.ca.

J Clin Virol ; 162: 105445, 2023 05.

Article de En | MEDLINE | ID: mdl-37043902

Sujet(s)
Mots clés

Direct acting antiviral therapy; Droplet digital PCR; HCV; HIV; Human pegivirus

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Infections à VIH / Hépatite C / Hépatite C chronique / Co-infection Type d'étude: Risk_factors_studies Limites: Female / Humans / Male Langue: En Journal: J Clin Virol Sujet du journal: VIROLOGIA Année: 2023 Type de document: Article Pays d'affiliation: Canada Pays de publication: Pays-Bas

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google